TAHEEBO JAPAN CO LTD has a total of 13 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are EXONATE LTD, DAJITI FARMAS JUTIKAL KO LTD and PRESIDIO PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Taiwan | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Fermentation | |
#5 | Special foods | |
#6 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Tokuda Harukuni | 9 |
#2 | Iida Akira | 5 |
#3 | Yamashita Mitsuaki | 4 |
#4 | Nishimura Katsumi | 4 |
#5 | Ueda Shinichi | 3 |
#6 | Hirai Keiichi | 3 |
#7 | Fukuda Yoichi | 2 |
#8 | Hatanaka Heihachi | 2 |
#9 | Mitsuaki Yamashita | 1 |
#10 | Kaneko Masafumi | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020161959A1 | Naphthoquinone compound having antibacterial and antiviral activities and pharmaceutical use thereof | |
CN102432569A | Novel preparation of anticancer-active tricyclic compounds via alkyne coupling reaction | |
US2010215625A1 | Efficient preparation of naphthoquinone anticancer active ingredients | |
US2008300415A1 | Preparation of Optically active 2-(1-hydroxyethyl)-5-hydroxynaphtho[2,3-b]furan-4, 9-diones having anticancer activities | |
WO2006098355A1 | Anticancer compound, intermediate therefor, and processes for producing these | |
CN1086815A | 2-(1-hydroxyethyl)-5-hydroxynaphtho{2,3-B}furan-4, 9-dione and antitumor agents comprising this compound |